BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li L, Zuo X, Liu D, Luo H, Zhang H, Peng Q, Wang G, Zhu H. Plasma exosomal RNAs has potential as both clinical biomarkers and therapeutic targets of dermatomyositis. Rheumatology (Oxford) 2021:keab753. [PMID: 34698812 DOI: 10.1093/rheumatology/keab753] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Li Q, Xu M, Zhang Z, Yin M, Zhang Y, Liu F. Urinary exosomal hsa_circ_0001250 as a novel diagnostic biomarker of idiopathic membranous nephropathy. J Transl Med 2022;20:607. [PMID: 36536378 DOI: 10.1186/s12967-022-03784-y] [Reference Citation Analysis]
2 Bozzini S, Zanframundo G, Bagnera C, Bozza E, Lettieri S, Vertui V, Codullo V, Cuzzocrea F, Atienza-Mateo B, Remuzgo Martinez S, Montecucco C, González-Gay MA, Cavagna L, Meloni F. A Proof-of-Concept Analysis of Plasma-Derived Exosomal microRNAs in Interstitial Pulmonary Fibrosis Secondary to Antisynthetase Syndrome. Int J Mol Sci 2022;23. [PMID: 36498905 DOI: 10.3390/ijms232314579] [Reference Citation Analysis]
3 Vuillier F, Li Z, Black I, Cruciani M, Rubino E, Michel F, Pellegrini S. IFN-I inducible miR-3614-5p targets ADAR1 isoforms and fine tunes innate immune activation. Front Immunol 2022;13:939907. [DOI: 10.3389/fimmu.2022.939907] [Reference Citation Analysis]